ClinicalTrials.gg
Active, not recruitingNCT05724823V-PASEUpdated Sep 23, 2026

Virtual Physical Activity Seated Exercise - Phase 2

An interventional study of Virtual Physical Activity Seated Exercises (V-PASE) in Stroke, Chronic Stroke and Stroke, Ischemic, sponsored by University of British Columbia. Active, not recruiting at 5 sites in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-23.

Sponsored by University of British Columbia · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 30 studies in Stroke by University of British Columbia — 3 open to participants now, 4 under way, none of them phase 3. Stroke · University of British Columbia.

Planned enrollment
9th of 25
100 · median 62
Started
2023
the only one that year
No phase
24 of 30
3 open now
Registered
27th of 30
by date

Among the 30 studies in Stroke by University of British Columbia, this one is the 9th largest by planned enrollment of the 25 interventional ones that give a count, is the only one that started in 2023, is one of 24 with no phase, and was the 27th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

3 of the 30 studies in Stroke by University of British Columbia are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 30 studies in Stroke by University of British Columbia, or all of them as a file.
02

Study summary

This study will determine the acceptability of delivering seated exercises online and if seated exercises can improve balance, mobility, quality of life, and cardiometabolic health in those living with a stroke related mobility impairment.

Participants will be allocated to either a 10-week seated exercise program or a delayed 2-week Boot Camp program. All seated exercises sessions and assessments will be conducted virtually.

Read the detailed description

The study will be a virtual 10-week multi-site, assessor-blinded, randomized controlled trial with an embedded qualitative component. The study will be conducted in real time using secure videoconferencing software (Zoom). Participants will be randomized 1:1 to a 10-week Seated Exercise group or a delayed 2-week Seated Exercise Group (Boot Camp). Seated exercise sessions will be delivered and supervised by a trained instructor.

Participants will use their own computer, laptop, or tablet for the zoom sessions. No Zoom sessions will be recorded. Caregivers will be invited to attend each exercise session to provide support and assistance but are not obliged to attend. A caregiver, friend, or family member will be required for each assessment to participate in the study.

03

Conditions studied

  • Stroke
  • Chronic Stroke
  • Stroke, Ischemic
  • Stroke Hemorrhagic

Keywords

  • Stroke
  • Seated Exercise
  • Balance
  • Mobility
  • Cardiometabolic health
  • Randomized Controlled Trial
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Participants must meet the following inclusion criteria:

  • Adult (as defined by Province)
  • Chronic stroke (more than 6 months post-stroke)
  • Ability to stand up from a chair
  • Mobility impairment of lower extremity (requires a walking aid, with or without close supervision)
  • Able to safely engage in exercise and tolerate 60 minutes of exercises
  • Able to communicate in English
  • Have access to a tablet, computer, or laptop with internet and email access

Exclusion criteria

Exclusion Criteria:

Participants will be excluded if they meet any of the following criteria:

  • Participating in formal exercise or rehabilitation activities
  • Participating in > 30 minutes/day of physical activity (moderate intensity)
  • Participating in another study that may affect outcomes to this study
  • Severe loss of vision, hearing, speech (including aphasia) or cognition that would preclude use of a computer/tablet and communication over videoconference software
  • A serious comorbid condition (eg., amputation, Parkinson's disease, active cancer)
  • Clinically diagnosed with acute/chronic illness or other condition which has known physical activity or limits their ability to complete each experimental condition (i.e., chronic low back pain aggravated by prolonged sitting)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    10-week group

    Will receive a 10-week seated exercise program, occurring 3 times per week. Sessions will be 60 minutes in duration.

    Other: Virtual Physical Activity Seated Exercises (V-PASE)

  • No intervention
    Delayed 2-week group (Boot Camp)

    The Boot Camp group will complete a 2-week seated exercise program following the 10-week active trial period.

Interventions

  • OtherVirtual Physical Activity Seated Exercises (V-PASE)

    The seated exercise program includes a variety of upper and lower limb strengthening, core strengthening, agility (fast arm and leg movements), and flexibility exercises. Participants will be supervised during each session thru videoconferencing by a trained instructor.

06

What researchers measure

Primary outcomes

  1. 30 Second Sit-to-Stand

    Assessment of balance and lower extremity strength.

    Time frame: Immediately post-intervention (following 10-week trial)

Secondary outcomes

  1. Timed Up and Go

    Participants stand up from a chair, walk 3 metres, turn around and then sit back down. The TUG assesses balance, mobility and turning ability

    Time frame: Immediately post-intervention, and retention (2-months post-intervention)

  2. Tandem Stance

    Measures balance in standing as reported in the Short Physical Performance Battery Protocol

    Time frame: Immediately post-intervention, and retention (2-months post-intervention)

  3. Modified Telehealth Fugl-Meyer

    The modified virtual Fugl-Meyer assess lower extremity impairments in those with stroke

    Time frame: Immediately post-intervention, and retention (2-months post-intervention)

  4. Stroke Impact Scale

    A self-reported measure of stroke-related disability. There are 8 domains with each item rated using a 5-point Likert scale, where lower scores mean greater difficulty to complete the item.

    Time frame: Immediately post-intervention, and retention (2-months post-intervention)

  5. Activities-Specific Balance Confidence (ABC)

    The ABC scale is a 16-item questionnaire where a participant rates their confidence in performing activities from 0% to 100% (higher percentages indicate greater self-efficacy).

    Time frame: Immediately post-intervention, and retention (2-months post-intervention)

  6. Fatigue Severity Scale

    Questionnaire assessing the impact of fatigue on daily tasks and activities. There are 9 questions, each scored from 1 to 7 (1 = strongly disagree; 7 = strong agreement).

    Time frame: Immediately post-intervention, and retention (2-months post-intervention)

  7. Quality of Life (EQ-5D-5L)

    The EQ-5D-5L assess self-care, mobility, depression/anxiety, pain, and usual activities. Each is scored with 5 levels (1=no problems, 5=major problems). Overall health on the day is scored from 0% (worst health) to 100% (best health).

    Time frame: Immediately post-intervention, and retention (2-months post-intervention)

  8. Patient Health Questionnaire-4 (PHQ-4)

    The PHQ-4 focuses on depression and anxiety. Questions are scored from 0 to 3 (0=not at all; 3 = Nearly every day).

    Time frame: Immediately post-intervention, and retention (2-months post-intervention)

  9. Montreal Cognitive Assessment scale (MoCA-BLIND)

    The MoCA-BLIND assess six different cognitive domains (excludes visual stimulus) over the phone: memory, attention, language, abstraction, delayed recall, and orientation. The MoCA-BLIND is scored from 0-22 (22 = no cognitive impairments).

    Time frame: Immediately post-intervention, and retention (2-months post-intervention)

  10. Lipid Profiles

    Blood samples will be collected following a 12-hour over-night fast

    Time frame: Immediately post-intervention, and retention (2-months post-intervention)

  11. Fasting Glucose

    Blood samples will be collected following a 12-hour over-night fast

    Time frame: Immediately post-intervention, and retention (2-months post-intervention)

  12. Glucose (HbA1c)

    Blood samples will be collected following a 12-hour over-night fast

    Time frame: Immediately post-intervention, and retention (2-months post-intervention)

  13. 30 Second Sit-to-Stand

    Assessment of balance and lower extremity strength.

    Time frame: Retention (2-months post-intervention)

Other outcomes

  1. Feasibility Indicator: Compliance

    Percentage of participants that attend exercise sessions.

    Time frame: Through study completion (approximately 10 weeks)

  2. Feasibility Indicator: Safety

    Number of adverse events that occur during assessments or exercise sessions.

    Time frame: Through study completion (approximately 10 weeks)

07

Study locations

5 sites
08

References and documents

Publications

  • Mackie P, Ashe MC, Barclay R, Bayley MT, Donkers SJ, Fleet JL, Mortenson WB, Peters S, Pollock CL, Pooyania S, Quigley A, Sakakibara BM, Schneeberg A, Sheehy L, Stelling S, Yao J, Eng JJ. Transferability of a 10-week remotely delivered Virtual Physical Activity Seated Exercise (V-PASE) program on post-stroke functional mobility: study protocol for a multisite randomized controlled trial. Trials. 2026 Feb 6;27(1):198. doi: 10.1186/s13063-026-09523-8. PubMed 41645237 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2023 (actual). Primary completion is estimated for Dec 2026, 38 months after the start.

Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 38 months is above that.

Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 17, 2023
First posted
Feb 13, 2023
StartActual
Oct 11, 2023
Primary completionEst.
Dec 31, 2026
CompletionEst.
Mar 31, 2027
Last update
Sep 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05724823
Collaborators
Canadian Institutes of Health Research (CIHR), Michael Smith Foundation for Health Research
Responsible party
Janice Eng (Professor, University of British Columbia) — Principal investigator
First posted
Feb 13, 2023
Start date
Oct 11, 2023
Primary completion
Dec 31, 2026 (estimated)
Completion
Mar 31, 2027 (estimated)
Last update
Sep 23, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion